Associated Papers
ERBB family fusions are recurrent and actionable oncogenic targets across cancer types.
Schubert L et al.
Frontiers in Oncology, 2023
37168365 (PubMed )
Supplement: Table_4.xlsx › ERBB4_mutations
Analysis of ERBB4 Variants in Amyotrophic Lateral Sclerosis Within a Chinese Cohort.
Wang F et al.
Frontiers in Neurology, 2022
35481267 (PubMed )
Supplement: Data_Sheet_1.PDF
Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.
Yin XQ et al.
Frontiers in Oncology, 2022
35936718 (PubMed )
Supplement: Table_4.xlsx › MAF_infomation
Select a paper to view details